ASCEND Neuro

Remarkable improvements
in dementia and cognitive decline are being reported

Dementia. Alzheimer’s. Parkinson’s.

One Reported Case Experience

Karen's Story. A severe dementia case, in her husband’s own words.

“82-year-old female at death’s doorstep, innocently doomed because she inherited double APOE4 genes, now can walk, talk, converse, plus a lot more. The miracle is here and now: yFFP.”

Baseline and after first treatment · Case Study 10

7-Week Update

At seven weeks, improvement continued. Her husband reports she is speaking coherently and even aspires to reopen a dance studio, as she was a professional ballerina when she was younger.

Functional Change

She walked three and a half blocks to a restaurant, without a walker or wheelchair, ate breakfast on her own, and walked back.

Physician Follow-Up

Cognitive and chemistry results checked out.

“This week the subject had her exam by her main physician. She passed her cognitive and physician tests, and her chemistries all checked out.”

Case Study 10 · Update 6/13/2026

Physician Response

The physician administering the treatment remained astonished at her turnaround.

Planned Continuation

Both wife and husband remained scheduled to each receive 3 liters of young plasma in July.

Published research studies and
more success stories are available.

ASCEND Neuro

Private inquiry. Personal review. Careful alignment.

For families facing dementia, Alzheimer’s, Parkinson’s, or cognitive decline, ASCEND Neuro is presented as a private, physician-directed pathway for exploring reported restoration of function.

Johnny Adams

Contact

Johnny Adams

CEO / Executive Director
Carl I. Bourhenne Medical Research Foundation /
Aging Intervention Foundation
-
BioFutures
Age Reversal Network
Gerontology Research Group
American Longevity Alliance

+1 512 717 2583 JAdams@AgingIntervention.org